Customized molecular diagnostics of bacterial bloodstream infections for carbapenem resistance: A convenient and affordable approach.
暂无分享,去创建一个
[1] Surojit Das. The crisis of carbapenemase-mediated carbapenem resistance across the human-animal-environmental interface in India. , 2022, Infectious diseases now.
[2] F. Tenover. Using Molecular Diagnostics to Develop Therapeutic Strategies for Carbapenem-Resistant Gram-Negative Infections , 2021, Frontiers in Cellular and Infection Microbiology.
[3] A. Hamprecht,et al. Detection of Multidrug-Resistant Enterobacterales—From ESBLs to Carbapenemases , 2021, Antibiotics.
[4] K. Walia,et al. Understanding complexities in the uptake of indigenously developed rapid point-of-care diagnostics for containment of antimicrobial resistance in India , 2021, BMJ Global Health.
[5] G. Hansen. Continuous Evolution: Perspective on the Epidemiology of Carbapenemase Resistance Among Enterobacterales and Other Gram-Negative Bacteria , 2021, Infectious Diseases and Therapy.
[6] P. Nordmann,et al. Epidemiology and Diagnostics of Carbapenem Resistance in Gram-negative Bacteria , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[7] E. Mylonakis,et al. Cost-effectiveness of molecular diagnostic assays for the therapy of severe sepsis and septic shock in the emergency department , 2019, PloS one.
[8] M. Chandy,et al. Rapid and economical detection of eight carbapenem-resistance genes in Enterobacteriaceae, Pseudomonas spp, and Acinetobacter spp directly from positive blood cultures using an internally controlled multiplex-PCR assay , 2019, Infection Control & Hospital Epidemiology.
[9] S. Essack,et al. Review of established and innovative detection methods for carbapenemase‐producing Gram‐negative bacteria , 2015, Journal of applied microbiology.
[10] Gilbert GREUB,et al. Microbial diagnosis of bloodstream infection: towards molecular diagnosis directly from blood. , 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[11] Eoin L. Brodie,et al. Use of 16S rRNA Gene for Identification of a Broad Range of Clinically Relevant Bacterial Pathogens , 2015, PloS one.
[12] Y. Glupczynski,et al. Validation of carbapenemase and extended-spectrum β-lactamase multiplex endpoint PCR assays according to ISO 15189. , 2013, The Journal of antimicrobial chemotherapy.